Olaf Stüve

Southwestern Medical Center — United States

Medicine · Health Sciences

71h-index21.1kcitations374works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(209), Polyomavirus and related diseases(67), Peripheral Neuropathies and Disorders(60), Immunotherapy and Immune Responses(57), T-cell and B-cell Immunology(34)

Publications371 total

Lipoic Acid for Treatment of Progressive Multiple Sclerosis
Neurology·2025· 2 citedOpen Access
Remyelination therapies are achievable in clinical practice—No
Multiple Sclerosis Journal·2025Open Access
Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions
Expert Opinion on Investigational Drugs·2025· 1 cited
Exploring the Association of Disease Modifying Therapies for Multiple Sclerosis and BTK Inhibitors with Epilepsy (P7-9.001)
Neurology·2025
Dynamics of spinal fluid immune cell alterations following cladribine tablet treatment in multiple sclerosis
2025· 1 cited
Tau in Multiple Sclerosis: A Review of Therapeutic Potential
Current Treatment Options in Neurology·2025· 3 citedOpen Access
The Knowns and Unknowns of Prion Protein in Immune Modulation and the Pathogenesis of Neuroautoimmune Diseases
Current Treatment Options in Neurology·2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System
Therapeutic Advances in Neurological Disorders·2025Open Access
List of contributors
Elsevier eBooks·2024Open Access
The immunology and pathophysiology of multiple sclerosis
Elsevier eBooks·2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
The Lancet Neurology·2024· 55 cited
Multiple sclerosis treatments a review of current biomedical engineering approaches
Biomaterials·2024· 8 cited
Dimethyl fumarate preserves brainstem and cervical spinal cord integrity in radiologically isolated syndrome
Journal of Neurology·2024· 6 cited
A T <sub>H</sub> 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation
Science Immunology·2024· 9 cited
Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database (P9-6.009)
Neurology·2024
Inverse Association Between Weight-loss Inducing Anti-hyperglycemic Agents and Multiple Sclerosis: Data Mining of the FDA Adverse Event Reporting System Database (P11-6.001)
Neurology·2024
Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
Therapeutic Advances in Neurological Disorders·2024· 4 citedOpen Access
Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Therapeutic Advances in Neurological Disorders·2024Open Access
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy
Therapeutic Advances in Neurological Disorders·2024· 3 citedOpen Access
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Therapeutic Advances in Neurological Disorders·2024· 14 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Bernhard Hemmer(14), Elliot M. Frohman(11), Michael K. Racke(10), Stephen C. Reingold(9), Gary Cutter(9), Per Soelberg Sørensen(8), Ruth Ann Marrie(8), Jeffrey A. Cohen(8), María Trojano(8), Bernd C. Kieseier(7), Hans-Peter Hartung(7), Scott S. Zamvil(6), Benjamin Greenberg(6), Nadia Reider(6), Emmanuelle Waubant(5), J. de Sèze(5), Jeffrey L. Bennett(5), Petra D. Cravens(5), Nancy Monson(5), Hans‐Peter Hartung(5)